Medtronic probed by US finance committee over GPO contract cancellation
This article was originally published in Clinica
Executive Summary
The chairman of the US Senate Finance Committee Max Baucus has launched an investigation into Medtronic's recent cancellations of its contracts with the country's top two group purchasing organisations (GPOs), Novation and Premier. The inquiry seeks to find out if the actions by the world's largest pure-play medtech company could reduce price transparency in the healthcare system and increase costs for patients.
You may also be interested in...
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Nose For A Good Tech? Philips Adds Nasal Alar Pulse Oximetry To Monitoring Portfolio
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.